Mercury Laboratories Ltd has reported Standalone financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 19.8584 crores during the period ended March 31, 2023 as compared to Rs. 16.8131 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 0.3665 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 0.6065 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 3.05 for the period ended March 31, 2023 as compared to Rs. 5.05 for the period ended December 31, 2022.
Total Income | ₹19.8584 crs | ₹16.8131 crs | 18.11% |
Net Profit | ₹0.3665 crs | ₹0.6065 crs | -39.57% |
EPS | ₹3.05 | ₹5.05 | -39.60% |
Financial Results (Q4 FY2023) - YoY Comparison The company has reported total income of Rs.19.8584 crores during the period ended March 31, 2023 as compared to Rs.13.9013 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.0.3665 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.0.8282 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.3.05 for the period ended March 31, 2023 as compared to Rs.6.90 for the period ended March 31, 2022.
Total Income | ₹19.8584 crs | ₹13.9013 crs | 42.85% |
Net Profit | ₹0.3665 crs | ₹0.8282 crs | -55.75% |
EPS | ₹3.05 | ₹6.90 | -55.80% |
Financial Results (Year Ended FY2023) - YoY Comparison The company has reported total income of Rs.77.0530 crores during the Financial Year ended March 31, 2023 as compared to Rs.58.7397 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.5.5788 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.3.5619 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.46.49 for the Financial Year ended March 31, 2023 as compared to Rs.29.68 for the Financial Year ended March 31, 2022.
Total Income | ₹77.0530 crs | ₹58.7397 crs | 31.18% |
Net Profit | ₹5.5788 crs | ₹3.5619 crs | 56.62% |
EPS | ₹46.49 | ₹29.68 | 56.64% |
Shares of Mercury Laboratories Ltd was last trading in BSE at Rs. 624.65 as compared to the previous close of Rs. 627.50. The total number of shares traded during the day was 279 in over 23 trades.
The stock hit an intraday high of Rs. 628.00 and intraday low of 606.00. The net turnover during the day was Rs. 171571.00.
Source : Equity Bulls
Keywords
MercuryLaboratories
Q4FY23
FY2023
ResultUpdate